Quarterly report [Sections 13 or 15(d)]

Stockholders' Equity (Details 1)

v3.26.1
Stockholders' Equity (Details 1) - Restricted Stock Units (RSUs) [Member] - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]        
Number of options outstanding at beginning of period 332 192 192  
Weighted average exercise price at beginning of period $ 394.64 $ 587.61 $ 587.61  
Weighted average remaining life (years) 1 year 1 month 13 days 2 years 1 month 28 days 1 year 4 months 6 days 1 year 6 months 29 days
Aggregate intrinsic value at beginning of period $ 3,157 $ 26,793 $ 26,793  
Number of options, Granted 217    
Weighted average grant - date fair value price, Granted $ 162.80    
Aggregate intrinsic value Granted $ 29,637    
Number of options, Exercised 0 0    
Weighted average exercise price, Exercised $ 0 $ 0    
Aggregate intrinsic value Exercised $ 0 $ 0    
Number of options, Forfeited/canceled (2) (17)    
Weighted average exercise price, Forfeited/canceled $ (162.80) $ (236.84)    
Aggregate intrinsic value Forfeited/canceled $ (19)    
Number of options outstanding at ending of period 330 392 332 192
Weighted average exercise price at ending of period $ 396.04 $ 367.66 $ 394.64 $ 587.61
Aggregate intrinsic value at ending of period $ 3,138 $ 56,430 $ 3,157 $ 26,793